首页 | 本学科首页   官方微博 | 高级检索  
     

纤溶酶治疗糖尿病合并急性脑梗塞的临床观察
引用本文:张新萍,张馨娜. 纤溶酶治疗糖尿病合并急性脑梗塞的临床观察[J]. 社区医学杂志, 2011, 9(14): 11-12
作者姓名:张新萍  张馨娜
作者单位:泰安市中心医院神经内科,山东,271000
摘    要:目的探讨纤溶酶治疗糖尿病性合并急性脑梗塞的疗效及其安全性。方法 98例糖尿病性脑梗塞患者,随机分成两组:治疗组和对照组,治疗组应用注射用纤溶酶100U加入250ml的0.9%氯化钠注射液中静滴;对照组则给予疏血通注射液6ml加入250ml的0.9%氯化钠注射液中静滴,用法均1次/日,连用2周,其余治疗相同。评价治疗前和治疗后2周的神经功能缺损以及临床疗效,观察不良反应,检测治疗前后血液纤维蛋白原(Fb)含量并进行比较。结果治疗后治疗组疗效显著优于对照组(P<0.05),纤维蛋白原(Fb)水平具有显著差异(P<0.05)。结论注射用纤溶酶对急性糖尿病性脑梗塞的近期疗效显著,能明显降低患者血液纤维蛋白原(Fb)含量,且无明显副作用。

关 键 词:纤溶酶  急性脑梗塞  糖尿病  临床疗效

Observation of the treatment effect of fibrinogenase on diabetic patients with acute cerebral infarction
ZHANG Xin-ping,ZHANG Xin-na. Observation of the treatment effect of fibrinogenase on diabetic patients with acute cerebral infarction[J]. journal of community medicine, 2011, 9(14): 11-12
Authors:ZHANG Xin-ping  ZHANG Xin-na
Affiliation:ZHANG Xin-ping,ZHANG Xin-na Neurology department of TaiAn Central Hospital,Taian Shandong 271000,China
Abstract:Objective To investigate the effects and safety of fibrinogenase on acute cerebral infarction in diabetic patients.Methods 98 cases of diabetic cerebral infarction were randomly divided into two groups: treatment group and control group,treatment group received fibrinogenase 100u Intravenous drip once a day,other drug treatments were the same with control group;control group was administrated with Shuxuetong etc.The course of treatment continued for 14 days.Neurological function score and clinical efficacy ...
Keywords:fibrinogenase  acute cerebral infarction  diabetes  clinical efficacy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号